Pancreatic Tumor Clinical Trial
Official title:
Phase II Study of First-line Stereotactic Body Radiation Therapy (SBRT) in Patients With Non-Metastatic Unresectable Pancreatic Cancer
The purpose of this study is to see if SBRT will be a better way to treat pancreas cancer and to find out what effects, good and/or bad, this treatment will have on participants and their cancer.
The standard treatment for cancer of the pancreas is surgery (if possible), external beam
radiation therapy and/or chemotherapy. These standard treatments are not a cure and often
extend life by just a few months. Recently, a new approach has been developed, called
stereotactic body radiation therapy (SBRT). Based on the results of earlier studies using
SBRT, the study doctors at Moffitt feel this is a reasonable alternative to the standard
treatment for your disease.
Stereotactic body radiation therapy (SBRT) delivers high radiation doses to the tumor every
day for 5 days which gives the usual 5-6 week course of radiation in less than a week. It
has also been shown to have much less side effects.
The purpose of this study is to see if SBRT will be a better way to treat pancreas cancer
and to find out what effects, good and/or bad, this treatment will have on you and your
cancer.
Six patients will be asked to be part of a subgroup called TBRI (Tissue, Blood, Research
Imaging). In this subgroup, the investigators want to study if there is early death of tumor
cells from the treatment by looking at the tumor using PET/CT scans and biopsies, and by
testing your body's white blood cells taken by a procedure called leukapheresis. You do not
have to take part in the TBRI subgroup to get treatment on this study with SBRT.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01673334 -
Evaluation of EUS-Guided 22 Gauge Core Biopsy Versus Fine-needle Aspiration for Suspected Pancreatic Neoplasms
|
Phase 4 | |
| Recruiting |
NCT01978808 -
Efficiency Study of the EUS-FNA Needles With and Without a Side Port in Pancreatic Masses
|
N/A | |
| Completed |
NCT01479803 -
Comparison of Two Needles (ProCore vs EchoTip) for the Diagnosis of Pancreatic Solid Mass Under EUS
|
Phase 3 | |
| Completed |
NCT02716207 -
Phase ǀ Study on Pancreatic Cancer Treated by CyberKnife
|
N/A | |
| Completed |
NCT03444051 -
Comparison of Two Endoscopic Biopsic Needles for Pancreatic Tumors
|
N/A | |
| Recruiting |
NCT05794048 -
METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors
|
N/A | |
| Recruiting |
NCT05871164 -
Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency
|
||
| Recruiting |
NCT03558945 -
Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic Tumor
|
Phase 1 | |
| Recruiting |
NCT01969110 -
Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy
|
Phase 4 | |
| Completed |
NCT02330497 -
Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic Tumor
|
N/A | |
| Completed |
NCT01692873 -
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
|
N/A | |
| Recruiting |
NCT04075305 -
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
|
||
| Recruiting |
NCT04357483 -
Effect of Thrombin-containing Collagen-based Hemostatic Matrix
|
Phase 4 | |
| Recruiting |
NCT01698190 -
Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal Lesions
|
N/A | |
| Active, not recruiting |
NCT03340844 -
Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary Tumors
|
N/A | |
| Withdrawn |
NCT02534246 -
Head to Head Comparison of Two Needles EUS Guided FNB
|
N/A | |
| Not yet recruiting |
NCT01819961 -
Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery
|
Phase 4 | |
| Withdrawn |
NCT02269683 -
Robotic vs. Laparoscopic Distal Pancreatectomy for Pancreatic Cancer
|
N/A |